Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Defining Nanotech Included In Working Group’s 10-Point Standardization Goal

This article was originally published in The Tan Sheet

Executive Summary

An International Organization for Standardization working group aims to define characteristics of nanotechnology drugs to help support regulatory development in this nascent field

You may also be interested in...

Consumer Groups Uneasy, FDA Cautious Over Nanotech In Supplements

Nanotechnology applications in dietary supplements and food additives demand FDA's immediate attention and guidance, consumer advocates say. Agency officials and industry groups, however, tend to support a more measured approach and show fewer signs of concern about nano products

Nanotech Report’s Recommendations Unsettling To Supplement Industry

Dietary supplement industry groups say an FDA panel's report citing the lack of information about working with nanotechnology should prompt the agency to be cautious about acting on the panel's recommendation to issue a guidance on using nano-materials in new dietary ingredients

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts